bioAffinity Technologies Inc. (BIAF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

bioAffinity Technologies ...

NASDAQ: BIAF · Real-Time Price · USD
2.61
-0.17 (-6.12%)
At close: Oct 03, 2025, 3:59 PM
2.60
-0.33%
After-hours: Oct 03, 2025, 07:59 PM EDT

bioAffinity Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
7.68M 8.81M 9.36M 9.37M 7.32M 4.94M 2.53M 321.49K 24.16K 5.72K 4.8K 2.46K 1.31K n/a n/a n/a n/a n/a
Cost of Revenue
5.39M 5.78M 6.13M 6.24M 4.87M 3.46M 1.74M 76.2K 1.64K 554.00 1.51K 2.13K 3.17K 4.21K 4.82K 4.02K 2.83K 1.64K
Gross Profit
2.29M 3.03M 3.23M 3.13M 2.45M 1.47M 791.62K 245.29K 22.51K 5.17K 3.3K 331.00 -1.86K -4.21K -4.82K -4.02K -2.83K -1.64K
Operating Income
-10.06M -9.64M -8.95M -8.35M -8.67M -8.36M -7.97M -7.25M -5.94M -4.84M -4.01M -3.05M -2.6M -2.44M -2.21M -2.35M -1.82M -1.29M
Interest Income
8.86K 12.03K 17.61K 25.7K 50.67K 89.6K 122.13K 155.83K 128.64K 84.79K 46.71K 1.25K 1.27K 990.00 424.00 106.45K 106.43K 106.43K
Pretax Income
-11.65M -9.72M -9.03M -8.43M -8.72M -8.35M -7.92M -7.22M -9.85M -8.2M -8.15M -12.05M -8.65M -7.08M -6.33M -2.88M -1.37M -2.85M
Net Income
-11.69M -9.74M -9.04M -8.45M -8.74M -8.37M -7.94M -7.24M -9.87M -8.21M -8.15M -12.06M -8.65M -7.08M -6.33M -2.89M -1.37M -2.85M
Selling & General & Admin
9.95M 10.21M 9.94M 9.24M 8.9M 7.83M 6.79M 5.76M 4.33M 3.28M 2.48M 1.59M 1.15M 1.05M 880.77K 982.33K 820.78K 578.17K
Research & Development
1.69M 1.66M 1.73M 1.74M 1.7M 1.67M 1.62M 1.29M 1.34M 1.3M 1.25M 1.42M 1.4M 1.35M 1.33M 1.37M 1M 714.76K
Other Expenses
710.46K 748.3K 460.19K 291.08K 197.85K 68.33K 85.5K 108.14K 50.57K 29.01K 411.52K 404.19K 404.19K 404.19K n/a n/a n/a n/a
Operating Expenses
12.36M 12.67M 12.18M 11.33M 10.89M 9.61M 8.54M 7.43M 5.96M 4.85M 4.02M 3.05M 2.6M 2.44M 2.21M 2.35M 1.82M 1.29M
Interest Expense
72.62K 84.41K 92.47K 92.75K 79.91K 59.02K 37.12K 108.5K 988.8K 1.39M 2.53M 3.07M 2.32M 2.04M 1M 363.83K 228.47K 111.55K
Selling & Marketing Expenses
n/a 2.22M 2.22M 2.22M 2.22M -21.55K -21.55K -131.63K -131.63K -110.07K -110.07K n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.74M 18.44M 18.32M 17.72M 15.99M 13.3M 10.51M 7.58M 5.96M 4.85M 4.02M 3.05M 2.6M 2.44M 2.21M 2.35M 1.82M 1.29M
Income Tax Expense
16.94K -6.63K -11.65K 13.94K 13.68K 12.85K 20.99K 20.86K 18.86K 14.28K 4.62K 2.46K 2.16K 2.16K 1.95K 1.95K 1.95K 1.95K
Shares Outstanding (Basic)
800.72K 541.9K 413.07K 413.07K 379.63K 330.5K 308.17K 289.88K 284.02K 281.12K 279.38K 140.13K 89.8K 89.37K 89.2K 90.93K 90.93K 90.93K
Shares Outstanding (Diluted)
800.72K 541.9K 413.07K 413.07K 379.63K 330.5K 308.17K 289.88K 284.02K 281.12K 279.38K 140.13K 90.93K 90.93K 90.93K 90.93K 90.93K 90.93K
EPS (Basic)
-21 -21.6 -22.8 -24.3 -27.3 -27.6 -27 -25.2 -52.5 -47.47 -58.27 -114.67 -96.67 -79.5 -71.4 -33 -15.9 -32.1
EPS (Diluted)
-20.7 -21.3 -22.5 -24.3 -27.3 -27.6 -27 -25.2 -52.5 -47.47 -58.27 -113.47 -94.87 -77.7 -69.3 -32.1 -15.6 -31.8
EBITDA
-11M -9.03M -8.33M -7.74M -8.14M -7.92M -7.63M -7M -8.8M -6.78M -6.01M -9.37M -6.73M -5.44M -5.32M -1.18M 199K -1.4M
EBIT
-11.58M -9.64M -8.94M -8.34M -8.64M -8.3M -7.88M -7.11M -8.86M -6.82M -6.02M -9.38M -6.73M -5.45M -5.32M -1.19M 192K -1.41M
Depreciation & Amortization
572.75K 610.59K 605.64K 600.79K 507.06K 377.55K 249.59K 108.14K 51.34K 30.83K 10.18K 3.65K 4.06K 4.21K 4.82K 6.36K 5.17K 3.98K